About Us
Powering the Next Era of Cancer Treatment
ALX Oncology is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.
Through compelling science and the tremendous potential of our pipeline, we are prepared to deliver the next generation of breakthrough therapies on which the future of treatment for cancer can be built.
Proven, Dynamic Leadership
ALX Oncology is led by a tenacious team of highly experienced drug developers who are uniquely capable and committed to delivering clinically meaningful oncology innovation.
Meet Our Leadership TeamInnovative Science
We are advancing a validated, differentiated scientific approach supported by ongoing, cutting-edge research that has demonstrated the ability to overcome challenges and the potential to meaningfully change the treatment paradigm for many cancers.
